Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Title Image
You are in:  / Home  /  Articles posted by indexa

Author: indexa

  RESEARCHER: Dr. Jesús Merayo Lloves  FINALIZADO    Efficacy and safety of T4020 versus its vehicle in patients with chronic neurotrophic keratitis or corneal ulcer. INDICATION: Patients with neurotrophic keratitis or neurotrophic corneal ulcer TREATMENT: Cacicol® PROMOTOR: Laboratoires THÉA

  RESEARCHER: Dr. Jesús Merayo Lloves  ACTIVO    A multicentre, randomized, double masked, 4-parallel, controlled, 6-month phase II study to assess the safety and efficacy of a cyclosporine PAD ophthalmic dispersion (0.06% and 0.03% CsA). Administered once daily in combination with lubricant therapy and safety

  RESEARCHER: Dr. Jesús Merayo Lloves  RECLUTANDO    "Double-blind, placebo-controlled phase I / II study to assess the efficiency and safety of AVX012 ophthalmic solution in subjects with mild to moderate dry eye" INDICATION: Pacientes con ojo seco leve o moderado TREATMENT: AVX-012 PROMOTOR: Avizorex Pharma

  RESEARCHER: Dr. Álvaro Fernández-Vega Sanz  ACTIVO    Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye. INDICATION: Patients with Macular Degeneration Associated with the